FHA
DNA icon

First Horizon Advisors’s Ginkgo Bioworks DNA Stock Holding History

First Horizon Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-760
Closed -$10.2K – 2337
2024
Q2 		$10.2K Sell
760
-56
-7% -$1.67K ﹤0.01% 1527
2024
Q1 		$37.9K Buy
816
+127
+18% +$6.57K ﹤0.01% 1086
2023
Q4 		$46.6K Buy
689
+80
+13% +$4.9K ﹤0.01% 969
2023
Q3 		$44.1K Sell
609
-189
-24% -$15.1K ﹤0.01% 906
2023
Q2 		$59.4K Buy
798
+116
+17% +$6.87K ﹤0.01% 816
2023
Q1 		$36.3K Buy
682
+168
+33% +$10.6K ﹤0.01% 1040
2022
Q4 		$34.8K Buy
514
+35
+7% +$3.22K ﹤0.01% 1013
2022
Q3 		$59K Buy
479
+72
+18% +$8.58K ﹤0.01% 779
2022
Q2 		$38K Buy
+407
New +$49.6K ﹤0.01% 1032

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return